As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 3/10/17  Lewis Michael E                   4          Officer²    1:5K   Cara Therapeutics, Inc.           DONNELLEY FIN… File16/FA 
 6/17/16  Lewis Michael E                   4          Officer²    1:5K   Cara Therapeutics, Inc.           DONNELLEY FIN… File16/FA 
 1/27/16  Lewis Michael E                   4          Officer²    1:4K   Cara Therapeutics, Inc.           DONNELLEY FIN… File16/FA 
  7/6/15  Lewis Michael E                   4          Officer²    1:4K   Cara Therapeutics, Inc.           DONNELLEY FIN… File16/FA 
  6/2/15  Lewis Michael E                   4          Officer²    1:4K   Cara Therapeutics, Inc.           DONNELLEY FIN… File16/FA 
  5/5/15  Lewis Michael E                   4          Officer²    1:4K   Cara Therapeutics, Inc.           DONNELLEY FIN… File16/FA 
  4/2/15  Lewis Michael E                   4          Officer²    1:4K   Cara Therapeutics, Inc.           DONNELLEY FIN… File16/FA 
  3/3/15  Lewis Michael E                   4          Officer²    1:4K   Cara Therapeutics, Inc.           DONNELLEY FIN… File16/FA 
  2/3/15  Lewis Michael E                   4          Officer²    1:4K   Cara Therapeutics, Inc.           DONNELLEY FIN… File16/FA 
  2/5/14  Lewis Michael E                   4          Officer²    1:8K   Cara Therapeutics, Inc.           DONNELLEY FIN… File16/FA 
 1/31/14  Lewis Michael E                   4          Officer²    1:5K   Cara Therapeutics, Inc.           DONNELLEY FIN… File16/FA 
 1/30/14  Lewis Michael E                   3          Officer²    2:9K   Cara Therapeutics, Inc.           DONNELLEY FIN… File16/FA 
 5/10/13  Lewis Michael E                   4          Director²   1:5K   Aeolus Pharmaceuticals, Inc.      Marketwired/FA           
  3/6/13  Lewis Michael E                   4          Director²   1:9K   Aeolus Pharmaceuticals, Inc.      Marketwired/FA           
 3/28/12  Lewis Michael E                   4          Director²   1:5K   Polymedix, Inc.                   Secs Transfer Corp./FA   
10/24/11  Lewis Michael E                   4          Director²   1:5K   Aeolus Pharmaceuticals, Inc.      Toppan Merrill/FA        
 1/25/11  Lewis Michael E                   4          Director²   1:5K   Polymedix, Inc.                   Secs Transfer Corp./FA   
 1/20/11  Lewis Michael E                   4          Director²   1:5K   Aeolus Pharmaceuticals, Inc.      Toppan Merrill/FA        
12/16/10  Lewis Michael E                   4          Director²   1:5K   Aeolus Pharmaceuticals, Inc.      Toppan Merrill/FA        
11/19/10  Lewis Michael E                   4          Director²   1:5K   Aeolus Pharmaceuticals, Inc.      Toppan Merrill/FA        

____________
¹	Filing/Form Types:  -A
	3	Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }.
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.